These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25431765)

  • 21. Aristolochic Acid in the Etiology of Renal Cell Carcinoma.
    Hoang ML; Chen CH; Chen PC; Roberts NJ; Dickman KG; Yun BH; Turesky RJ; Pu YS; Vogelstein B; Papadopoulos N; Grollman AP; Kinzler KW; Rosenquist TA
    Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1600-1608. PubMed ID: 27555084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urothelial lesions in Chinese-herb nephropathy.
    Cosyns JP; Jadoul M; Squifflet JP; Wese FX; van Ypersele de Strihou C
    Am J Kidney Dis; 1999 Jun; 33(6):1011-7. PubMed ID: 10352187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
    Grollman AP
    Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the renal toxicity caused by aristolochic acids (AAs) and Chinese herbs containing AAs].
    Liang AH; Ding XS; Liu BY
    Zhongguo Zhong Yao Za Zhi; 2004 Jan; 29(1):10-4. PubMed ID: 15709371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products--a consequence of inappropriate nomenclature and imprecise labelling?
    Cheung TP; Xue C; Leung K; Chan K; Li CG
    Clin Toxicol (Phila); 2006; 44(4):371-8. PubMed ID: 16809138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
    Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
    Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
    J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aristolochic acid and its effect on different cancers in uro-oncology.
    Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T
    Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese herbs and urothelial carcinoma.
    Li YM
    N Engl J Med; 2000 Oct; 343(17):1269; author reply 1269-70. PubMed ID: 11183354
    [No Abstract]   [Full Text] [Related]  

  • 31. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
    De Broe ME
    Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.
    Schmeiser HH; Kucab JE; Arlt VM; Phillips DH; Hollstein M; Gluhovschi G; Gluhovschi C; Modilca M; Daminescu L; Petrica L; Velciov S
    Environ Mol Mutagen; 2012 Oct; 53(8):636-41. PubMed ID: 22987305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Vanherweghem JL
    Toxicology; 2002 Dec; 181-182():577-80. PubMed ID: 12505369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
    Wang SM; Lai MN; Wei A; Chen YY; Pu YS; Chen PC; Wang JD
    PLoS One; 2014; 9(8):e105218. PubMed ID: 25170766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.
    Yang HY; Yang CC; Wu CY; Wang LJ; Lu KL
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?
    Cosyns JP; Dehoux JP; Guiot Y; Goebbels RM; Robert A; Bernard AM; van Ypersele de Strihou C
    Kidney Int; 2001 Jun; 59(6):2164-73. PubMed ID: 11380818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational signature of aristolochic acid: Clue to the recognition of a global disease.
    Rosenquist TA; Grollman AP
    DNA Repair (Amst); 2016 Aug; 44():205-211. PubMed ID: 27237586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective toxicity of aristolochic acids I and II.
    Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP
    Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation and Toxicities of Aristolochic Acids.
    Sidorenko VS
    Adv Exp Med Biol; 2020; 1241():139-166. PubMed ID: 32383120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market.
    Martena MJ; van der Wielen JC; van de Laak LF; Konings EJ; de Groot HN; Rietjens IM
    Anal Bioanal Chem; 2007 Sep; 389(1):263-75. PubMed ID: 17486320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.